111 related articles for article (PubMed ID: 2568798)
21. Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate.
Krutzén E; Bäck SE; Nilsson-Ehle I; Nilsson-Ehle P
J Lab Clin Med; 1984 Dec; 104(6):955-61. PubMed ID: 6438261
[TBL] [Abstract][Full Text] [Related]
22. Biodistribution and excretion of 125I ioversol in conscious dogs.
Coveney JR; Robbins MS
Invest Radiol; 1989 Jun; 24 Suppl 1():S23-7. PubMed ID: 2592170
[TBL] [Abstract][Full Text] [Related]
23. Tolerance and excretion of iohexol after intravenous injection in healthy volunteers. Preliminary report.
Aakhus T; Sommerfelt SC; Stormorken H; Dahlström K
Acta Radiol Suppl; 1980; 362():131-4. PubMed ID: 6267886
[No Abstract] [Full Text] [Related]
24. Safety and toleration of the non-ionic contrast medium iopentol. An intravenous phase I trial.
Jakobsen JA; Hagve TA; Holager T; Waaler A; Haider T; Andrew E; Aakhus T
Eur J Radiol; 1989 Nov; 9(4):203-7. PubMed ID: 2591384
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of iopentol in the rat.
Michelet AA; Skinnemoen K
Acta Radiol Suppl; 1987; 370():101-4. PubMed ID: 2980301
[TBL] [Abstract][Full Text] [Related]
26. Iotrolan, a nonionic dimeric contrast medium in myelography.
Bien S; Schumacher M; Berger W; Wenzel-Hora BI
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():158-60. PubMed ID: 2568785
[TBL] [Abstract][Full Text] [Related]
27. Human pharmacokinetics of iohexol. A new nonionic contrast medium.
Olsson B; Aulie A; Sveen K; Andrew E
Invest Radiol; 1983; 18(2):177-82. PubMed ID: 6408018
[TBL] [Abstract][Full Text] [Related]
28. Indirect lymphography with iotrolan.
Partsch H; Stöberl C; Wruhs M; Wenzel-Hora BI
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():178-81. PubMed ID: 2568790
[TBL] [Abstract][Full Text] [Related]
29. Recent development in non-ionic contrast media.
Hagen B
Ann Radiol (Paris); 1989; 32(1):38-9. PubMed ID: 2742324
[TBL] [Abstract][Full Text] [Related]
30. Whole body autoradiographic distribution studies on nonionic x-ray contrast agents in pregnant rats.
Täuber U; Mützel W; Schulze PE
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():215-9. PubMed ID: 2568799
[TBL] [Abstract][Full Text] [Related]
31. A new animal model for testing renal tolerance of contrast agents.
Krause W; Gilles T
Invest Radiol; 2003 Nov; 38(11):704-11. PubMed ID: 14566180
[TBL] [Abstract][Full Text] [Related]
32. Safety and pharmacokinetics of ioversol in healthy volunteers.
Wilkins RA; Whittington JR; Brigden GS; Lahiri A; Heber ME; Hughes LO
Invest Radiol; 1989 Oct; 24(10):781-8. PubMed ID: 2793391
[TBL] [Abstract][Full Text] [Related]
33. Cytokine profiles after nonionic dimeric contrast medium injection.
Böhm I; Speck U; Schild H
Invest Radiol; 2003 Dec; 38(12):776-83. PubMed ID: 14627895
[TBL] [Abstract][Full Text] [Related]
34. Acute intravenous toxicity of iohexol in the mouse and in the rat.
Salvesen S
Acta Radiol Suppl; 1980; 362():73-5. PubMed ID: 6267895
[TBL] [Abstract][Full Text] [Related]
35. Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in the rat kidney.
Ueda J; Nygren A; Hansell P; Ulfendahl HR
Acta Radiol; 1993 Jan; 34(1):83-7. PubMed ID: 8427755
[TBL] [Abstract][Full Text] [Related]
36. Biodistribution and imaging characteristics of iotrolan-carrying interdigitation-fusion vesicles.
Seltzer SE; Janoff AS; Blau M; Adams DF; Minchey SR; Boni LT
Invest Radiol; 1991 Nov; 26 Suppl 1():S169-71; discussion S175-6. PubMed ID: 1808119
[No Abstract] [Full Text] [Related]
37. Hemorrheologic effects of iotrolan after intra-arterial injection in rabbits: comparison with other types of contrast media.
Nauert C; Langer M; Mützel W
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():40-5. PubMed ID: 2568806
[TBL] [Abstract][Full Text] [Related]
38. [The new nonionic contrast preparation for myelography iotrolan].
Sviridov NK
Zh Vopr Neirokhir Im N N Burdenko; 1994; (2):35-6. PubMed ID: 8209595
[No Abstract] [Full Text] [Related]
39. Comparison of the nonionic contrast agents, iopromide and iotrolan, for positive-contrast arthrography of the scapulohumeral joint in dogs.
van Bree H; Van Rijssen B; Tshamala M; Maenhout T
Am J Vet Res; 1992 Sep; 53(9):1622-6. PubMed ID: 1416366
[TBL] [Abstract][Full Text] [Related]
40. Safety and pharmacokinetics of iotrolan in hysterosalpingography. Retention and irritability compared with Lipiodol.
Miyamoto Y; Tsujimoto T; Iwai K; Ishida K; Uchimoto R; Miyazawa T; Azuma H
Invest Radiol; 1995 Sep; 30(9):538-43. PubMed ID: 8537211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
